While Prempro may cure your hot flashes, it may also debilitate or kill you from ovarian cancer, breast cancer, endometrial cancer, and stroke.
Since 1995, millions of women have confidently taken Prempro, a leading hormone replacement therapy drug, prescribed to treat postmenopausal hot flashes and other menopausal symptoms.
However, a recent major study concludes that long-term use of Prempro has significantly increased the risk of stroke, blood clots, Prempro ovarian cancer, endometrial cancer, and breast cancer, while maximizing the risk for dementia and Alzheimer’s disease. Evidence has revealed that Prempro and other estrogen progestin combinations can actually harm perfectly healthy women.
These results were found in the nation's largest hormone replacement study and were so alarming that the National Institute of Health (NIH) prematurely canceled the study citing risk to the participants. As a result the study is suggesting that many of the women who use Prempro and other estrogen and progestin combinations should quit and talk to their doctors about Prempro alternatives.
Prempro is manufactured by Wyeth Pharmaceuticals. In 2001 Prempro accounted for approximately $890 million of the company's $13.9 billion in sales.
Monheit Law is investigating Prempro Cancer cases for long term users of Prempro who have developed either breast or ovarian cancer.
See: http://www.monheit.com/prempro/problem.shtml for the original text of this article.
About the Author
Monheit Law is investigating Prempro Cancer cases for long term users of Prempro who have developed either breast or ovarian cancer.
New!
Watch Online Articles with YouTube for Free:
|
